US Medicaid Programs Say Cost a Key Factor for Weight-loss Drug Coverage, Survey Finds

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their Medicaid health programs for low income people, citing…
Reuters Health Information